Key Highlights of the Cancer Biomarker Market 2025-2034: Growth Dynamics, Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Forecasted Expansion Rate of the Cancer Biomarker Market Over the 2025–2034 Period?
The cancer biomarker market size has grown rapidly in recent years. It will grow from $22.19 billion in 2024 to $25.28 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to shift to personalized medicine, immunotherapy innovations, regulatory framework evolution, collaborative research efforts, focus on non-coding RNAs.
The cancer biomarker market size is expected to see rapid growth in the next few years. It will grow to $45.88 billion in 2029 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to shift to patient-centric diagnostics, integration of biomarkers in clinical trials, emergence of multiplex biomarker panels, exploration of non-coding RNAs, commercialization of biomarker tests. Major trends in the forecast period include advancements in genomics, precision medicine approaches, liquid biopsies, immunotherapy advancements, artificial intelligence (ai) integration.
What External and Internal Drivers Are Contributing to the Growth of the cancer biomarker Market’s Growth?
The rising incidence of cancer is driving the growth of the cancer biomarker market. The cancer incidence rate is the number of new cancers of a specific site/type that occur in a given population during a given year, represented as cancers per 100,000 people at risk. The increasing incidence of cancer is leading to the widespread use of cancer biomarkers because it helps in assessing disease risk, screening for occult primary tumors, identifying benign from malignant signs, or separating one form of malignancy from another. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. Therefore, the rising incidence of cancer packaging is expected to propel the growth of the cancer biomarker market in the coming years.
Get Your Free Sample of the Global Cancer Biomarker Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8492&type=smp
Who Are the Leading Organizations Fueling the Expansion of the Cancer Biomarker Market?
Major companies operating in the cancer biomarker market are:
• F. Hoffmann-La Roche AG_x000D_
• Thermo Fisher Scientific Inc._x000D_
• QIAGEN NV_x000D_
• Illumina Inc._x000D_
• Bio-Rad Laboratories Inc._x000D_
Which Cutting-Edge Trends Are Expected to Drive the Cancer Biomarker Market’s Growth?
Major companies operating in the cancer biomarker market are focusing on developing innovative solutions, such as AI-powered cancer biomarkers, to enhance diagnostic accuracy and personalize treatment plans for patients. AI-powered cancer biomarkers refer to biological indicators of cancer that are identified and analyzed using artificial intelligence technologies. For instance, in September 2023, Ibex Medical Analytics, a US-based Ibex Medical Analytics, launched Galen Breast HER2, an AI-powered solution designed to enhance the accuracy and reproducibility of HER2 scoring in breast cancer patients. This innovative platform aids pathologists by automatically detecting invasive tumor areas and quantifying HER2 expression based on the 2018 ASCO/CAP guidelines. The Galen Breast HER2 system utilizes a novel computational pipeline to analyze immunohistochemistry (IHC)-stained slides, providing detailed visualizations of staining patterns and enabling pathologists to make informed treatment decisions.
Get Instant Access to the Global Cancer Biomarker Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
What Are the Core Categories and Segments in the Cancer Biomarker Market Driving Demand and Growth?
The cancer biomarker market covered in this report is segmented –
1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers
2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers
4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications
Subsegments:
1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Protein
2) By Genetic Biomarkers: DNA Mutations, RNA Expression Profiles
3) By Other Cancer Biomarkers: Epigenetic Biomarkers, Metabolomic Biomarkers
Which Regions Are Most Influential in Expanding the Cancer Biomarker Market?
North America was the largest region in the cancer biomaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Parameters Define the Cancer Biomarker Market’s Scope?
A cancer biomarker refers to a biological molecule present in the blood, tissues, or other bodily fluids, that indicates the presence of normal or abnormal activity, as well as a condition or disease. Cancer biomarkers are used to characterize alterations in the tumor.
Browse Through More Similar Reports By The Business Research Company:
Lung Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Skin Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
